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We  have  previously observed  that  a  point  mutation  on  chromosome  13  in  the 
mouse, called beige, leads to a  marked, selective impairment in natural-killer (NK) a- 
cell function  (1). Because beige mice have long been used as an animal model of the 
Ch~diak-Steinbrinek-Higashi syndrome (C-HS) in man (2) it seemed relevant to assess 
NK function in humans who bear this rare, autosomal recessive gene. Because of the 
marked  propensity  of C-HS  patients  for  developing  lymphoproliferative disorders 
that  may  be  malignant  (3)  it  was  predicted  that  if NK  cells  in  the  human  were 
important  in immune surveillance, then  C-H  patients might  have low levels of NK 
activity. 
In this present paper we show that NK activity in two C-HS donors was profoundly 
impaired and did not appear to be a  result of an alteration of an anti-target selectivity 
pattern or of the kinetics of lysis, of suppressor cells, of a  lack of ability to respond to 
interferon, or of a  lack of target-cell recognition. In the accompanying paper  (4)  we 
show that antibody-dependent cell-mediated cytotoxicity against tumor-cell targets is 
also depressed in C-HS  patients with  cytolytic activity by monocytes,  by polymor- 
phonuclear leukocytes, and by T  cells that are relatively normal. 
Materials  and  Methods 
Subjects.  Two male patients, Le. R.  (age 26 yr), and  La. R.  (age: 28  yr), siblings from a 
consanguinous marriage, and eight different age- and sex-matched normal controls were studied 
in parallel experiments on three separate occasions over a  l-mo period. The detailed clinical 
history and many previous experiments on these particular patients has been described (5-7). 
At the time of study the patients were free of overt infections and were not on therapy. 
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Cell Lines.  All cell lines were maintained by continuous in vitro culture and were free of 
mycoplasma at  the time of testing. The following cell  lines were used:  K562: derived from 
human  myeloid leukemia;  Molt-4:  a  T  cell  line derived  from  human  acute  lymphocytic 
leukemia; Alab, GEM, and MDA human breast cancer cells; TU5:SV40 virus-transformed 
mouse kidney cells; P815: methylcholanthrene-induced  mastocytoma of mice; and human fetal 
fibroblasts: nontransformed primary cell culture, passaged five times. 
Effector Cells.  Heparinized venous blood was  centrifuged (1,000 g  for  10 min) on Ficoll- 
Hypaque  (LSM;  Litton  Bionetics,  Kensington, Md)  and  the  mononuclear cell  band  was 
collected. 
Cell Fractionations.  Mononuclear cells were depleted of monocytes by adherence (45 rain at 
37°C)  to  plastic surfaces  coated  by microexudates of detached  TU5 kidney cells  grown  to 
confluence as described previously (8). Cell loss was -20% in all donors and contamination of 
recovered  lymphocytes was  <2%  monocytes as judged  by  phagocytosis  of latex  beads  or 
nonspecific esterase  staining and <2% polymorphonuclear leukocytes (PMN) as indicated by 
Wright's-stained cytocentrifuge preparations or staining with monoclonal anti-human PMN 
antibody generously provided by Dr. P. Beverley,  University College Hospital, London. 
Mononuclear cells (30 ×  106/ml) were also incubated for 60 min at 37°C on a 7-ml column 
of preswollen Sephadex G-10 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, 
N. J.) or on a  10-ml column of scrubbed nylon wool  (Fenwal Inc., Walter Kidde & Co.  Inc., 
Ashland, Mass.) equilibrated with RPM 1-1640, containing 20% fetal calf serum (FCS)  (Grand 
Island Biological  Co., Grand Island, N. Y.), and nonadherent cells were washed through with 
three bed volumes of warm, 37°C medium. Cell recovery was 60% of input and macrophage 
contamination, as indicated by uptake of latex beads, was <2%. 
To obtain lymphocytes with receptors for the Fc portion of IgG (FcR+),  mononuclear cells 
were depleted of monocytes by a  1-h incubation on plastic surfaces.  Lymphocytes were then 
incubated for 60 rain at room temperature in plastic flasks (Falcon Labware, Div. of Becton, 
Dickinson & Co.,  Oxnard Calif.) precoated with trinitrophenylated (TNP)  FCS and rabbit 
anti-TNP antibody (9). Nonadherent lymphocytes without receptors for the Fc portion of IgG 
(FcR-) were recovered, and adherent FcR÷ cells were eluted with EDTA and by scraping with 
a rubber policeman. Both FcR  + and FcR- fractions were incubated overnight at 37°C, before 
assay, to allow recovery of cell surface receptors. 
Interferon Treatment.  Lymphocytes were incubated 1 h with 103 units (National Institutes of 
Health reference standard) of partially purified human fibroblast interferon (HEM Laborato- 
ries, Rockville, Md.) or medium as control and washed two times before use. 
Target-binding Assay.  Lymphocyte populations, depleted of adherent cells by passage over 
Sephadex  G-10 or  nylon-wool columns, were  mixed with  a  fivefold  excess  of tumor cells, 
centrifuged at  150 g for 5 min, incubated 5 min at 37°C, and then stored on ice. Pellets were 
gently resuspended, and the number of lymphocytes binding to tumor cells  (target-binding 
cells [TBC])  was determined in a hemocytometer. 
Cytolytic Assays.  Target cells labeled with 51Cr (sodium chromate) were placed together with 
varying numbers of effector cells in 0.2-ml microwells (Linbro Chemical Co., Hamden, Conn.) 
in triplicate samples. The microplates were spun at room temperature for 5 min, at  1,000 rpm, 
and then were  incubated for 4  h.  at  37°C.  Supernate was  measured  in a  gamma counter 
(Beckman Instruments, Inc., Fullerton, Calif.). Autolysis was determined by culturing 51Cr- 
labeled targets alone, and total label was determined by counting an aliquot of targets after 
resuspension in the microwells.  The following formula was used to compute the percent lysis: 
test counts per minute -  autolysis 
percent lysis =  total counts per minute  ×  100. 
Lytic Units.  Lytic units (LU) were calculated from effector  titration curves and  1 LU was 
defined as the number of effector  cells required to achieve a given percent lysis. 
Results 
Functional  Defect  of NK Cells in the C-HS.  In this study, two male C-HS donors and 
eight age- and sex-matched normal controls were studied in parallel experiments on 
three separate occasions over a  l-too period.  As shown in Fig.  1,  C-HS  peripheral HALIOTIS ET AL.  1041 
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FIG.  1.  NK activity in CH-S patients. Peripheral blood mononuclear cells, depleted of monocytes 
on microexudates were tested for cytolysis against K562, Alab, Moh-4, CEM, MDA, and human 
fetal fibroblast targets at  varying effector:target ratios, in a 4-h 51Cr-release assay. Autolysis by 
target culture alone was always <20%. subjects: (O) J. J. (normal); (O) J. G. (normal); •  Le. R. (C- 
HS); (11) La. R. (C-HS); (A) J. R. (normal); (1"-I)  j. O. (normal). Values represent mean percent 
lysis of triplicate wells ± SE. The absence of vertical bars indicates the standard error is contained 
within the symbol. The experiment was repeated for a total of three times for K562, three times for 
Moh-4, and one time for Alab, CEM, MDA, and human fetal fibroblasts. Murine lines, AT6, P815, 
and RBL-5 were not lysed by normal cells or C-HS donors. 
blood mononuclear cells had very low cytolytic activity against  K562 target cells, in 
contrast  to  the  consistently  high  levels  of the  normal  donors.  A  similarly  large 
difference in reactivity was seen with five other target cells. The LU/106 calculated at 
20% lysis were <1  to <0.1  for both C-HS patients  tested against all targets,  whereas 
normal donors yielded mean values of 90, 40, and  13 against  K562, Alab, and Molt- 
4, respectively.  The target  cells were chosen to represent  a  wide spectrum,  from the 
highly NK-sensitive, human tumor-cell lines  (K562, Moh-4, and Alab)  to those that 
are relatively resistant to lysis by some donors (MDA and CEM) or normal, nontrans- 
formed fetal fibroblasts (10). Several murine lines,  (AT6, P815, and RBL-5) were not 
lysed by normal cells or C-HS donors. The cells from the C-HS patients had little or 
no  reactivity  against  any  of the  targets  indicating  a  general  impairment  in  NK 
cytolytic activity. However, it should be stated that although the NK response in C- 
HS against these targets was significantly lower than that of controls, a small titratable 
response (5-10% lysis) was obtained against the most sensitive targets. 
Cold-Target Competition.  To investigate  the specificity of the low level of cytolytic 
activity of the C-HS patients, a cold-target inhibition assay was performed using SlCr- 
labeled K562 (a highly sensitive NK target)  as the hot target and unlabeled P815 (an 
NK-insensitive  target)  or  unlabeled  K562  as  the  cold  targets,  competing  with  the 
labeled  K562.  As shown in Fig.  2, natural  cytotoxic activity of normal effectors was 
significantly  (P <  0.05)  inhibited  in the  presence of cold K562  targets,  whereas  the 
presence of cold P815 targets  had little  or no effect  (P >  0.05).  Similar  trends were 
obtained  with  C-HS effectors although  levels of lysis were  much  lower  (Fig.  2,  low 
panel). This suggests that the small residual cytolysis by C-HS effectors has the same 
or similar specificity as NK cells in the normal donors. 
Kinetics of NK Function.  One possible explanation for the low reactivity of cells from 
the C-HS patients was that they needed more time than allowed by the usual natural 1042  NATURAL-KILLER-CELL  IMMUNODEFICIENCY 
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FIG.  2.  Cold-target  inhibition  assay.  Unfractionated  peripheral  blood  mononuclear cells  were 
tested for cold-target inhibition in a  4-h 5]Cr-release assay against labeled K562 targets at varying 
competitor:labeled-target  ratios.  K562 autolysis was 6.2%.  Subjects and preparations:  (0)  G.  B. 
(normal) +  labeled K562 +  unlabeled P815;  (O) G. B. +  labeled K562 +  unlabeled K562;  (A) B. 
S. (normal) +  labeled K562 +  unlabeled I)815;  (A) B. S. +  labeled K562 +  unlabeled K562;  (1) 
Le. R. (C-HS) +  labeled K562 +  unlabeled P815;  (I-1) Le. R. (C-HS) +  labeled K562 +  unlabeled 
K562;  (41) La.  R.  (C-HS)  +  labeled  K562  +  unlabeled  P815;  (<2>) La.  R.  +  labeled  K562  + 
unlabeled K562. 
cytotoxicity assay to express normal levels. Therefore, a kinetic study was performed 
in which lysis was evaluated at eight time points over a  period of 17 h. As shown in 
Fig.  3 the NK response of C-HS donors against  K562 remained quite low over this 
entire period. Similar results were obtained in a repeat experiment carried out for up 
to 24 h. of incubation. Thus, the C-HS deficiency did not appear to constitute a delay 
in the expression of a normal level of NK activity. 
Enrichment of NK Cells.  It was important to enrich for NK cells from C-HS patients, 
to  reduce  the  possibility  that  the  apparent  defect  was  a  result  of  inhibition  or 
suppression  by contaminating  cell  types.  Peripheral  blood  mononuclear  cells  were 
passed through a  nylon-wool column or a  Sephadex G-10 column. As shown in Fig. 
4,  column-passed  cells  from  normal  subjects  exhibited  an  increase  in  lytic ability, 
whereas this did not occur with the cells of the C-HS patients.  Fractionation of NK 
cells  from  normal  donors  on  immune  complex  monolayers  resulted  in  high  NK 
activity in the FcR+ fraction eluted from the monolayer, whereas the FcR-, nonad- 
herent  fraction  exhibited  little  cytolytic  activity.  FcR+  cells  from  C-HS  donors, 
although  slightly  enriched  for NK activity, yielded  only low  levels of NK activity 
comparable to the FcR- fraction from normal donors. 
Absence of Suppressor Cell Activity  in  C-HS Cell Populations.  To further examine the 
possibility that the low NK reactivity of the C-HS patients might be a  result of the 
presence of a suppressor cell rather than of a characteristic of the NK cell per se, cells 
from a C-HS donor were mixed with cells from a normal subject, at varying inhibitor: 
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FIG.  3.  Kinetics of NK  activity.  Peripheral  blood  mononuclear  cells, depleted  of monocytes on 
microexudate-coated  plastic, were tested for cytolysis against K562 targets at a  25:1 effector:target 
ratio at varying times over a  17-h period. Values represent mean percent lysis of triplicate wells ± 
SD.  Subjects:  (O) J. J.  (normal);  (A) J. G.  (normal);  (1-7) Le.  R.  (C-HS);  (A) La.  R.  (C-HS);  (C)) 
autolysis. 
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F~c.  4.  NK  activity  in  fractionated  blood.  Peripheral  blood  mononuclear  cells were  untreated 
(open symbols) or were fractionated by passage through Sephadex G-10 (left panel) or nylon-wool 
(middle panel) columns (closed symbols), or over immune complex-coated plates (right panel), and 
tested  for cytolytic  activity against  K562  in a  4.5-h ~Cr-release  assay,  at  varying effector:target 
ratios.  (E:T =  50:1, right panel). Values represent mean percent lysis of triplicate wells. Autolysis 
of target cells alone was 21.6, 7.8, and 7.9%, respectively (left to right). Subjects: circles and squares: 
J. G. (normal), triangles: Le. R. (C-HS).  (I-q) FcR-; (~1) FcR +. 
population, it might suppress the activity not only of C-HS NK cells, but of NK cells 
derived from the normal subject as well. 
As shown in Fig. 5, C-HS cells did not inhibit cytolysis by normal cells. To rule out 
the possibility that suppression was masked by an enhancing allogeneic effect, ceils 
were mixed from a  normal donor and as shown, no enhancement or suppression was 
evident.  Thus,  it  is  unlikely  that  the  NK  defect  in  C-HS  donors  was  a  result  of 
inhibitory cells. 
Binding ofC-HS Lymphocytes to Target Cells.  In contrast to the impairment in natural 
killing, the frequency of nylon-passed and Sephadex G-10-passed lymphocytes binding 
to K562 and Molt-4 targets wasessentially normal in C-HS patients (Table I). P815, 
an  NK-insensitive  target  was  not  bound  by  either  normal  or  C-HS  donor  cells. 
Therefore, the C-HS defect most likely lies within  the lytic mechanism rather than 
within the recognition structure involved in target-effector interaction. 1044  NATURAL-KILLER-CELL IMMUNODEFICIENCY 
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Fro.  5.  Absence of suppressor  cell activity in C-HS-cell populations. Varying numbers of unfrac- 
tionated peripheral  blood mononuclear cells  from a  C-HS donor,  Le.  R.  (inhibitor),  or from a 
normal donor, J~d., and a normal subject, J. G. (attacker),  were mixed at varying ratios and then 
tested  in a  4-h  Cr-release  assay  for NK activity against  K562  target cells. Also shown  are the 
results from the inhibitor cells alone added to K562. Values represent mean percent lysis of triplicate 
wells. Autolysis was  15.1%. Subjects:  (m) j. G.; (0) J. G. +  Le. R.; (O) Le. R, (control);  (&) J. G. 
+ J. J. (control);  (A) J. J. (control). 
TABLE  I 
TBC 
Experi-  Donor  Fractionation 
ment 
Percent TBC 
K562  Moh-4  P815 
1  J.G.  (normal)  Sephadex G- 10-passed  15  37 
Le. R. (C-HS)  15  46 
2  G.B. (normal)  Nylon-wool-passed  20  41  1.0 
B. S. (normal)  28  34  2.6 
Le. R. (C-HS)  25  36  4.0 
Ficoll-Hypaque,separated peripheral blood lymphocytes were passed  over nylon-wool or Sephadex G-10 
columns to remove adherent cells, and then mixed with a fivefold excess of tumor cells. Values represent 
the percentage of lymphocytes binding to targets. 
Augmentation of NK Activity by Interferon.  Interferon  (IF) has been shown to augment 
NK activity in humans  (11) as well as in the mouse (12). As shown in Fig. 6, treatment 
of peripheral blood mononuclear  cells for 1 h  with human  fibroblast IF enhanced  NK 
activity to  a  variable extent  in  normals.  Subject J.  O.  was  boosted  from  33  LU/106 
(calculated  at  20% lysis)  to 89 LU/10 n, whereas subject J.  R. was boosted  to a  lesser 
extent  from  133  LU/10 n to  174  LU/10 n.  In  the  C-HS  donors,  IF also  significantly 
boosted  NK  activity, but  the  levels remained  much  depressed  compared  to those of 
the normal donors. Activity rose from 0.02 LU/10 n to  1.0 LU/10 n for Le. R. and from 
0.02 LU/10 n to 3.3 LU/10 n for La. R. Similar results were observed when Molt-4 was 
used  as  target  (data  not  shown).  These  results  indicate  that  NK  cells  from  C-HS 
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Flc.  6.  The effect  of IF on  the  NK response. The natural  cytolytic activity of IF-treated  cells 
(right panel) was compared with that of cells that had not been treated with IF (left panel) in a 4- 
h 5]Cr-release assay against K562 targets at varying effector:target cell ratios. Values represent mean 
percent  lysis of triplicate wells +  SD Autolysis was 5.4%.  Subjects:  (O) J.  R.  (normal);  (O) J.  O. 
(normal); (7)  I,e. R.; (I-])  La. R. (C-HS). 
TABLE  II 
In  Vitro Generation of NK Activity 
Without stimulators 
Donors  With stimulators 
Control  IF 
LU/IO s* 
B. S. (normal)  84  131  150 
G. B. (normal)  12  21  41 
Le. R. (C-HS)  <0.1  <0.1  <0.1 
La. R. (C-HS)  <0. l  <0.1  <0.1 
Peripheral blood mononuclear cells were cultured 7 d with or without a  pool 
of irradiated stimulator cells from four normal donors as described previously 
(13).  Effectors were harvested, treated with or without IF, and tested in a  4-h 
5]Cr-release assay against K562 cells. 
* Calculated as the number of cells required to produce 30% specific lysis. 
In  Vitro Generation of NK  Activity.  It  was  of interest  to  determine  whether  the 
defective NK activity of C-HS patients  might  be reversed during  in  vitro culture. 
Peripheral blood lymphocytes were cultured  7 d  as described previously (13).  In the 
absence  of stimulator  cells,  normal  donors  exhibited  12-84  LU/106  against  K562 
target cells, whereas C-HS donors had <0.1  LU/106  (Table II). IF pretreatment of 
cultured  effector cells enhanced  NK activity almost twofold in normal cells but did 
not induce detectable activity in the cells from the C-HS donors. Furthermore, normal 
cells,  but  not  C-HS cells,  cocultured  with  a  pool of irradiated  stimulators  showed 
significant enhancement of NK activity against K562. These results suggest that the 
C-HS defect in NK function persists in vitro and may even be exacerbated because 
cultured lymphocytes from C-HS donors had no detectable response to IF. 
Discussion 
The overall conclusions  from the  data  presented  was that  NK activity was pro- 
foundly depressed in the two cases of C-HS that were available for study. 1046  NATURAL-KILLER-CELL  IMMUNODEFICIENCY 
Spontaneous cytolytic activity of nonadherent, FcR  + lymphocytes against several 
NK-sensitive targets  was at  least  100-fold greater in  age- and  sex-matched normal 
donors compared to the C-HS donors, in short-term, 4-h 51Cr-release  assays. The low 
NK activity in C-HS donors was not simply a result of a delayed response because the 
defect was still  evident in a  17- to 24-h cytolytic assay. In addition, we screened both 
adherent  and  suspension  target-cell  lines  of both  transformed and  nontransformed 
phenotypes  selected  to  represent  a  wide  spectrum  of NK-susceptible  target  cells. 
Therefore,  the  defective  C-HS  response  was  not  simply  a  result  of a  shift  in  the 
selectivity of cytotoxic activity. It should be noted that although the NK response of 
C-HS donors was low, it was not entirely absent. C-HS effector ceils mediated cytolysis 
of K562, the most sensitive NK target known, and sometimes reached levels  of 15% 
lysis at the highest effector:target ratio  (Fig.  1);  this response titrated  and increased 
with time of incubation  (Fig.  3).  In addition, the NK response in both normal cells 
and  C-HS donors was  inhibited  in  cold-target  competition  assays.  The  low C-HS 
response was boosted significantly by IF but the levels  after treatment remained very 
low relative to those seen with normal donors. The possibility that this response is not 
a  result of residual NK cells  but rather may represent contaminating promonocytes, 
which  also exhibit  IF-boostable, NK-like activity, at  least  in  the  mouse, cannot be 
excluded (14). 
We  then  asked  whether  the  low  NK  response  in  C-HS  donors  was  a  result  of 
suppressor  cells.  When  low-responder C-HS  cells  were  mixed  with  normal  cells  at 
ratios as high as 2:1, no suppression of cytolysis was observed. In addition, the removal 
of adherent cells,  a  suggested source of NK suppressors (15),  did not restore the NK 
response in C-HS donors. Furthermore, the C-HS defect persisted after 7 d of in vitro 
culture in the absence of host hurnoral factors. Therefore it is unlikely that the C-HS 
defect is a result of suppressor cells  or factors. 
The nature of the NK defect is  not  entirely known, but  may lie  within  the lytic 
pathway rather than at the level  of the recognition structure or NK population size. 
Hence,  the  frequency of lymphocytes binding to  NK-sensitive targets  was  normal. 
The  majority  of TBC  (80%) detected  in  this  assay  have  been  shown  to  lyse  their 
targets in the mouse (16-17). In the human, preincubation of effectors with solubilized 
glycoproteins from NK-sensitive targets specifically inhibits the formation of TBC by 
50%  (18).  Although not  all  human TBC  are  cytolytic NK cells,  the  proportion of 
TBC that  are  NK cells  is  large enough to  detect  any differences  in  C-HS donors. 
Because  TBC  frequency was  normal  in  C-HS  patients,  we  can  assume  that  NK 
frequency may also be normal. 
In summary, we have described  the  first  primary  immunodeficiency disorder  in 
humans  selectively  involving NK  cells  alone  as  shown  in  the  following paper  (4). 
Other  studies  of the  more  familiar  immunodeficiencies  failed  to  reveal  significant 
defects in NK function (19), except in the case of severe combined immunodeficiency 
(2O). 
It  is  interesting  to  note  that  C-HS  patients  surviving  early  infections  almost 
invariably succumb to lymphoproliferative disorders that some investigators feel are 
malignant (3). The finding of a marked deficiency of NK function provides a possible 
explanation for this and is consistent with the suggested role of NK cells  in immune 
surveillance (21).  If NK deficiency leads to malignancy, then IF therapy may benefit 
these patients because we have shown here that C-HS cells  treated  in vitro with  IF HALIOTIS ET AL.  1047 
have enhanced NK activity. In addition, because we are unaware of reports of other 
nonlymphoid tumors in these C-HS patients, then these observations may restrict the 
validity of the NK surveillance theory to the lymphoreticular system. 
Summary 
Natural-killer  (NK)-cell function was profoundly depressed in donors homozygous 
for  the  Ch~diak-Steinbrinck-Higashi  syndrome (C-HS)  gene  when  compared with 
age-  and  sex-matched  normals.  This  apparent  defect  was  not  simply a  result  of a 
delayed response because little cytolysis was evident in kinetics experiments even after 
24 h of incubation. NK cells  from C-HS donors failed to lyse adherent  (MDA, CEM, 
and  Alab)  or nonadherent  (K562  and  Molt-4)  tumor cell  lines  or nontransformed 
human fetal  fibroblasts.  Therefore,  the apparent  C-HS defect was not a  result  of a 
shift in target selectivities.  In addition, the depressed reactivity did not appear to be 
a  result  of suppressor cells  or factors because:  (a)  enriched NK populations  (nonad- 
herent  lymphocytes bearing receptors for the Fc portion of IgG) from C-HS donors 
were  low  in  NK-cell  function,  (b)  C-HS  mononuclear  cells  did  not  inhibit  the 
cytotoxicity of normal  cells  in  coculture experiments,  and  (c)  cells  from  the  C-HS 
donors remained poorly reactive even after culture for up to  7 d. The nature of the 
defective  NK  activity  in  C-HS  patients  is  not  clear  but  may  lie  within  the  lytic 
mechanism rather  than  at  the level  of the  recognition structure or population size 
because the frequency of target-binding cells was normal. In vitro NK activity could 
be partially restored by interferon treatment. Combined with the results presented in 
the  following  paper  (4),  these  observations  suggest  that  the  C-HS  gene  causes  a 
selective  immunodeficiency disorder,  mainly  involving  NK  cells.  This  finding,  in 
conjunction with the high incidence of spontaneous possibly malignant, lymphopro- 
liferative disorders in these patients,  may have important implications regarding the 
theory of immune surveillance mediated by NK cells. 
Received for publication  10 December 1979. 
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